낭포성 섬유증용 기도 클리어런스 기기 시장 보고서(2026년)
Airway Clearance Devices For Cystic Fibrosis Global Market Report 2026
상품코드 : 1939206
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,629,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,583,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,536,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

낭포성 섬유증용 기도 클리어런스 기기 시장 규모는 최근 현저한 성장을 달성하고 있습니다. 2025년 27억 3,000만 달러에서 2026년에는 28억 9,000만 달러로, CAGR 5.6%로 확대가 전망되고 있습니다. 지난 수년간의 성장에는 낭포성 섬유증 진단 건수 증가, 환자 생존율 향상, 호흡치료기 보급 확대, 재택의료 서비스 확대, 기도 청소 요법에 대한 인지도 향상 등이 주요 요인으로 꼽힙니다.

낭포성 섬유증용 기도 클리어런스 기기 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 35억 8,000만 달러에 달하며, CAGR은 5.5%에 달할 전망입니다. 예측 기간 중의 성장세는 개인 맞춤형 호흡기 케어에 대한 관심 증가, 커넥티드 호흡기 기기 보급 확대, 원격의료를 활용한 CF 관리 확대, 경량 및 휴대용 시스템에 대한 수요 증가, 호흡기 기기 혁신에 대한 투자 증가 등이 요인으로 작용할 것으로 보입니다. 예측 기간의 주요 동향으로는 휴대용 기도확보장치의 도입 증가, 재택 호흡관리 솔루션에 대한 수요 증가, 웨어러블 흉부 진동 시스템의 보급 확대, 소아 전용 디자인의 확대, 환자의 편안함과 순응도 향상에 대한 집중도 강화 등이 있습니다.

폐 질환의 발생률 증가는 가까운 미래에 낭포성 섬유증용 기도 청소 장치 시장의 확대를 촉진할 것으로 예측됩니다. 폐 질환은 과도한 점액 생성 및 폐 기능 장애를 유발하는 질환으로, 기도를 깨끗하게 하고 호흡기 건강을 개선하는 효과적인 솔루션에 대한 수요가 증가하고 있습니다. 이러한 폐질환 증가는 대기오염의 악화, 흡연, 담배 소비 증가 등 여러 가지 상호 연관된 요인에 기인하며, 이 모든 것이 호흡기 질환과 장기적인 폐 손상에 크게 기여하고 있습니다. 고주파 흉벽 진동(HFCWO) 조끼, 호기말 양압(PEP) 장치, 진동식 PEP 장치와 같은 기도 클리어런스 장치는 기도내 점성 점액을 분해하고 제거하는 데 매우 중요한 역할을 합니다. 특히 점성이 높고 끈적끈적한 점액으로 인해 만성 폐 감염과 호흡곤란을 겪는 낭포성 섬유증 환자들에게 특히 도움이 됩니다. 예를 들어 2024년 3월 미국 질병예방통제센터(CDC)의 발표에 따르면 결핵 발병 건수는 2022년 8,320건에서 2023년 9,615건으로 1,295건 증가했습니다. 이처럼 폐질환의 유병률 증가는 낭포성 섬유증에서 기도 청소 장치 시장을 촉진할 것으로 예측됩니다.

낭포성 섬유증용 기도확보장치 시장에서 사업을 운영하고 있는 주요 기업은 고주파 흉벽 진동 기술 등 기술 혁신에 주력하고 있습니다. 이를 통해 점액 제거 효율 향상, 환자 편의성 향상, 치료 기간 단축, 비침습적 재택 치료 옵션 제공, 궁극적으로 낭포성 섬유증 환자의 임상적 결과와 삶의 질 향상에 기여하고 있습니다. 고주파 흉벽 진동 기술은 고속 공기 펄스를 사용하여 흉벽 전체에 진동을 발생시켜 점액의 이완과 이동을 촉진하고 폐에서 쉽게 배출할 수 있도록 하는 치료법입니다. 예를 들어 2024년 9월 미국 헬스케어 기업 박스터 인터내셔널(Baxter International)은 북미 낭포성 섬유증 컨퍼런스에서 차세대 기도 청소 시스템인 'Vest Advanced Pulmonary Experience(APX) 시스템'을 발표했습니다. Best APX 시스템은 기존 기기의 검증된 기류 기술을 계승하면서 임상의와 환자의 의견을 바탕으로 편안함의 향상과 환자 중심의 기능을 통합했습니다. 특정 만성 폐질환 및 분비물 정체로 인한 성인 및 소아의 일상적인 치료를 지원하는 것을 목표로 하고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

Airway clearance devices for cystic fibrosis are medical instruments designed to assist in clearing mucus from the lungs, thereby improving respiratory function and reducing the likelihood of lung infections. These devices are primarily used to manage respiratory symptoms, boost lung function, and enhance the quality of life for individuals with cystic fibrosis or other chronic respiratory conditions.

The key types of airway clearance devices for cystic fibrosis include vest systems, intrapulmonary percussive ventilators (IPV), positive expiratory pressure (PEP) devices, high-frequency chest wall oscillation (HFCWO) devices, and other related devices. Vest systems are wearable devices that use rapid air pulses to help clear mucus from the lungs. These devices are used by both adult and pediatric patients with cystic fibrosis. They are commonly found in hospitals, clinics, home healthcare settings, and other healthcare environments.

Tariffs are influencing the airway clearance devices for cystic fibrosis market by increasing costs of imported medical-grade plastics, electronic components, sensors, pneumatic systems, and wearable device modules. Healthcare providers in North America and Europe are most affected due to reliance on imported specialized components, while Asia-Pacific faces pricing pressure on device manufacturing and exports. These tariffs are increasing device costs and reimbursement challenges for patients. However, they are also encouraging local manufacturing, regional sourcing of components, and innovation in cost-efficient airway clearance technologies.

The airway clearance devices for cystic fibrosis market research report is one of a series of new reports from The Business Research Company that provides airway clearance devices for cystic fibrosis market statistics, including airway clearance devices for cystic fibrosis industry global market size, regional shares, competitors with a airway clearance devices for cystic fibrosis market share, detailed airway clearance devices for cystic fibrosis market segments, market trends and opportunities, and any further data you may need to thrive in the airway clearance devices for cystic fibrosis industry. This airway clearance devices for cystic fibrosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The airway clearance devices for cystic fibrosis market size has grown strongly in recent years. It will grow from $2.73 billion in 2025 to $2.89 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to rising prevalence of cystic fibrosis diagnoses, improved survival rates among cf patients, increased availability of respiratory therapy devices, expansion of home healthcare services, growing awareness of airway clearance therapies.

The airway clearance devices for cystic fibrosis market size is expected to see strong growth in the next few years. It will grow to $3.58 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to increasing focus on personalized respiratory care, rising adoption of connected respiratory devices, expansion of telehealth-supported cf management, growing demand for lightweight and portable systems, increasing investments in respiratory device innovation. Major trends in the forecast period include increasing adoption of portable airway clearance devices, growing demand for home-based respiratory care solutions, rising use of wearable chest oscillation systems, expansion of pediatric-specific device designs, enhanced focus on patient comfort and compliance.

The growing incidence of lung disorders is anticipated to drive the expansion of the airway clearance devices market for cystic fibrosis in the near future. Lung disorders are conditions that result in the excessive production of mucus and impaired lung function, leading to an increasing demand for effective solutions to clear airways and enhance respiratory health. This rise in lung disorders can be attributed to various interconnected factors, including increased air pollution, smoking, and tobacco consumption, all of which significantly contribute to respiratory diseases and long-term lung damage. Airway clearance devices such as high-frequency chest wall oscillation (HFCWO) vests, positive expiratory pressure (PEP) devices, and oscillatory PEP devices play a crucial role in breaking up and clearing thick mucus from the airways, which is especially beneficial for cystic fibrosis patients who suffer from thick and sticky mucus that causes chronic lung infections and breathing problems. For example, in March 2024, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported a rise in tuberculosis cases, from 8,320 in 2022 to 9,615 in 2023, reflecting an increase of 1,295 cases. Thus, the growing prevalence of lung disorders is expected to drive the market for airway clearance devices in cystic fibrosis.

Major companies operating in the airway clearance devices for cystic fibrosis market are concentrating on technological innovations such as high-frequency chest wall oscillation technology to improve the efficiency of mucus clearance, enhance patient comfort, shorten treatment duration, and offer non-invasive, home-based treatment options, ultimately contributing to improved clinical outcomes and quality of life for individuals with cystic fibrosis. High-frequency chest wall oscillation technology is a therapeutic approach that employs rapid air pulses to generate vibrations across the chest wall, facilitating the loosening and movement of mucus for easier elimination from the lungs. For example, in September 2024, Baxter International Inc., a US-based healthcare company, introduced its next-generation airway clearance system, the Vest Advanced Pulmonary Experience (APX) System, at the North American Cystic Fibrosis Conference. The Vest APX System maintains the proven airflow technology of its predecessor while integrating enhanced comfort and patient-centric features based on input from clinicians and patients. It is intended to support daily therapy for both adults and children with certain chronic lung conditions and retained secretions.

In September 2023, Inogen Inc., a US-based medical technology company, acquired Physio-Assist SAS for an undisclosed amount. Through this acquisition, Inogen intends to expand its respiratory care portfolio and address the growing and underserved airway clearance market, particularly with the Simeox device for bronchiectasis and other chronic respiratory conditions. Physio-Assist SAS, based in France, specializes in airway clearance and mucus management devices.

Major companies operating in the airway clearance devices for cystic fibrosis market are Koninklijke Philips N.V., Baxter International Inc., ICU Medical Inc., Vyaire Medical Inc., Tactile Systems Technology Inc., RespirTech, Mercury Medical Inc., Electromed Inc., Vitality Medical Inc., Monaghan Medical Corporation, Pulmodyne Inc., PARI GmbH, Flexicare Limited, D.R. Burton Healthcare Limited, Intersurgical Ltd., Clement Clarke International Ltd., Thayer Medical Inc., AirPhysio, VORTRAN Medical Technology Inc., Med Systems Inc., Wave Healthcare

North America was the largest region in the airway clearance devices for cystic fibrosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the airway clearance devices for cystic fibrosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the airway clearance devices for cystic fibrosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The airway clearance devices for cystic fibrosis market consists of sales of incentive spirometers, manual chest physiotherapy (CPT) devices and nebulizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Airway Clearance Devices For Cystic Fibrosis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses airway clearance devices for cystic fibrosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for airway clearance devices for cystic fibrosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The airway clearance devices for cystic fibrosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Airway Clearance Devices For Cystic Fibrosis Market Characteristics

3. Airway Clearance Devices For Cystic Fibrosis Market Supply Chain Analysis

4. Global Airway Clearance Devices For Cystic Fibrosis Market Trends And Strategies

5. Airway Clearance Devices For Cystic Fibrosis Market Analysis Of End Use Industries

6. Airway Clearance Devices For Cystic Fibrosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Airway Clearance Devices For Cystic Fibrosis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Airway Clearance Devices For Cystic Fibrosis Total Addressable Market (TAM) Analysis for the Market

9. Airway Clearance Devices For Cystic Fibrosis Market Segmentation

10. Airway Clearance Devices For Cystic Fibrosis Market Regional And Country Analysis

11. Asia-Pacific Airway Clearance Devices For Cystic Fibrosis Market

12. China Airway Clearance Devices For Cystic Fibrosis Market

13. India Airway Clearance Devices For Cystic Fibrosis Market

14. Japan Airway Clearance Devices For Cystic Fibrosis Market

15. Australia Airway Clearance Devices For Cystic Fibrosis Market

16. Indonesia Airway Clearance Devices For Cystic Fibrosis Market

17. South Korea Airway Clearance Devices For Cystic Fibrosis Market

18. Taiwan Airway Clearance Devices For Cystic Fibrosis Market

19. South East Asia Airway Clearance Devices For Cystic Fibrosis Market

20. Western Europe Airway Clearance Devices For Cystic Fibrosis Market

21. UK Airway Clearance Devices For Cystic Fibrosis Market

22. Germany Airway Clearance Devices For Cystic Fibrosis Market

23. France Airway Clearance Devices For Cystic Fibrosis Market

24. Italy Airway Clearance Devices For Cystic Fibrosis Market

25. Spain Airway Clearance Devices For Cystic Fibrosis Market

26. Eastern Europe Airway Clearance Devices For Cystic Fibrosis Market

27. Russia Airway Clearance Devices For Cystic Fibrosis Market

28. North America Airway Clearance Devices For Cystic Fibrosis Market

29. USA Airway Clearance Devices For Cystic Fibrosis Market

30. Canada Airway Clearance Devices For Cystic Fibrosis Market

31. South America Airway Clearance Devices For Cystic Fibrosis Market

32. Brazil Airway Clearance Devices For Cystic Fibrosis Market

33. Middle East Airway Clearance Devices For Cystic Fibrosis Market

34. Africa Airway Clearance Devices For Cystic Fibrosis Market

35. Airway Clearance Devices For Cystic Fibrosis Market Regulatory and Investment Landscape

36. Airway Clearance Devices For Cystic Fibrosis Market Competitive Landscape And Company Profiles

37. Airway Clearance Devices For Cystic Fibrosis Market Other Major And Innovative Companies

38. Global Airway Clearance Devices For Cystic Fibrosis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Airway Clearance Devices For Cystic Fibrosis Market

40. Airway Clearance Devices For Cystic Fibrosis Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기